These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy. Joseph S; Vingill S; Jahn O; Fledrich R; Werner HB; Katona I; Möbius W; Mitkovski M; Huang Y; Weis J; Sereda MW; Schulz JB; Nave KA; Stegmüller J J Neurosci; 2019 Jul; 39(28):5606-5626. PubMed ID: 31085610 [TBL] [Abstract][Full Text] [Related]
4. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis. Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039 [TBL] [Abstract][Full Text] [Related]
5. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
6. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339 [TBL] [Abstract][Full Text] [Related]
7. White matter involvement after TBI: Clues to axon and myelin repair capacity. Armstrong RC; Mierzwa AJ; Marion CM; Sullivan GM Exp Neurol; 2016 Jan; 275 Pt 3():328-333. PubMed ID: 25697845 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease. Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515 [TBL] [Abstract][Full Text] [Related]
9. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. Vavlitou N; Sargiannidou I; Markoullis K; Kyriacou K; Scherer SS; Kleopa KA J Neuropathol Exp Neurol; 2010 Sep; 69(9):945-58. PubMed ID: 20720503 [TBL] [Abstract][Full Text] [Related]
10. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. Jackson SJ; Lee J; Nikodemova M; Fabry Z; Duncan ID J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease. Hertzog N; Jacob C Neural Regen Res; 2023 Sep; 18(9):1931-1939. PubMed ID: 36926710 [TBL] [Abstract][Full Text] [Related]
12. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356 [TBL] [Abstract][Full Text] [Related]
13. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. Smith CM; Cooksey E; Duncan ID J Neurosci; 2013 Feb; 33(6):2718-27. PubMed ID: 23392698 [TBL] [Abstract][Full Text] [Related]
14. A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication. Shackleford G; Marziali LN; Sasaki Y; Claessens A; Ferri C; Weinstock NI; Rossor AM; Silvestri NJ; Wilson ER; Hurley E; Kidd GJ; Manohar S; Ding D; Salvi RJ; Feltri ML; D'Antonio M; Wrabetz L PLoS Genet; 2022 Nov; 18(11):e1010477. PubMed ID: 36350884 [TBL] [Abstract][Full Text] [Related]
15. Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease. Nobbio L; Gherardi G; Vigo T; Passalacqua M; Melloni E; Abbruzzese M; Mancardi G; Nave KA; Schenone A Eur J Neurosci; 2006 Mar; 23(6):1445-52. PubMed ID: 16553608 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. McGavern DB; Murray PD; Rodriguez M J Neurosci Res; 1999 Nov; 58(4):492-504. PubMed ID: 10533042 [TBL] [Abstract][Full Text] [Related]
17. Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy. Ravera S; Nobbio L; Visigalli D; Bartolucci M; Calzia D; Fiorese F; Mancardi G; Schenone A; Morelli A; Panfoli I J Neurochem; 2013 Jul; 126(1):82-92. PubMed ID: 23578247 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396 [TBL] [Abstract][Full Text] [Related]
20. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]